Importantly, the potential of splicetopes in cancer therapy was suggested by the fact that adoptive transfer of splicetope-specific CD8+ T cells into the autologous melanoma patient was shown to be followed by tumor regression (16). The gene discussed is CD8A; the disease is melanoma.